DRC‑Rwanda Border Reopens After Months‑Long Ebola‑Related Closure
On Thursday evening the border crossing between the Democratic Republic of Congo (DRC) and Rwanda was reopened, ending a closure that had lasted since May because of the Ebola outbreak affecting the region. The announcement came in a press release from the M23 rebel coalition, which currently controls Goma, the capital of North Kivu province.
Why the Border Was Closed
Health authorities shut the crossing in May after laboratory‑confirmed cases of the Bundibugyo strain of Ebola were detected in Goma. Although the city recorded only a single case, officials feared that unrestricted movement could spread the virus to neighboring Rwanda and beyond. The World Health Organization (WHO) has repeatedly warned that blanket border closures can hinder outbreak response by disrupting the flow of medical supplies, personnel, and accurate information.
Effects on Goma’s Economy and Daily Life
With Goma’s international airport closed since the M23 takeover, residents have relied heavily on cross‑border trade and travel to meet basic needs. Goods courier Didier Mbombo described the hardship:
“We are really happy that the border reopened today because our lives depend on it. While the border was closed, we could not provide for our families.”
Trader Joviale Bigombire echoed the sentiment, noting that work had become difficult without the ability to purchase supplies in Rwanda:
“I am happy about the reopening of the border crossing because it has already been a month and a half since we were able to travel to Rwanda.”
Health Situation and WHO Guidance
As of the latest reports, the Ebola outbreak in the eastern DRC has resulted in more than 1,400 confirmed cases and over 400 deaths. The Bundibugyo virus, which is less common than the Zaire strain, circulated undetected for weeks while health teams focused on testing for the more prevalent variant.
The WHO continues to advise against closing borders, emphasizing that such measures can exacerbate the outbreak by limiting access to essential resources. Instead, the organization recommends targeted screening, rapid diagnosis, and strengthened surveillance at points of entry.
Looking Ahead: Treatment Trials and Ongoing Challenges
On the same day the border reopened, clinical trials began in Goma for an experimental therapeutic aimed at treating Bundibugyo‑related Ebola. Currently, there is no licensed vaccine or specific treatment for this strain, making the trial a critical step toward expanding the medical toolkit.
Travelers seeking international flights must still route through Kigali, Rwanda’s capital, as Goma’s airport remains closed. This detour often requires crossing active front lines in a conflict that has persisted for three decades, adding risk and complexity to any journey.
Key Facts at a Glance
- Border between DRC and Rwanda reopened late Thursday after a May closure linked to Ebola.
- Goma’s airport has been shut since the M23 takeover, increasing reliance on cross‑border movement.
- One laboratory‑confirmed Bundibugyo case was reported in Goma; the wider outbreak has caused >1,400 cases and >400 deaths.
- WHO advises against border closures, recommending targeted screening and sustained surveillance.
- Clinical trials for a Bundibugyo‑specific treatment started Thursday; no vaccine or approved therapy exists yet.
- International travel from Goma now requires transit via Kigali, navigating ongoing conflict zones.
